Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 3/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16625803 | 0.86 | MTNR1B (0.47) | PDE4DMTNR1BCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL12744529 | 0.86 | PDE4D (0.42) | PDE4DMTNR1BMTNR1ACYP4F2CYP4A11 | |
| SCHEMBL16625812 | 0.83 | MTNR1B (0.46) | MTNR1BCYP3A4CYP2D6CYP2C19MEN1 | |
| SCHEMBL16625797 | 0.81 | GRIN2C (0.50) | MTNR1BLMNAMAPTNPSR1 | |
| SCHEMBL16627050 | 0.79 | MTNR1B (0.60) | MTNR1BCYP3A4CYP2D6CYP2C19MTNR1A | |
| SCHEMBL9637922 | 0.77 | LMNA (0.61) | PDE4DMTNR1BCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL11921686 | 0.77 | GAA (0.47) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL16625795 | 0.76 | DRD2 (0.45) | MTNR1BCYP3A4CYP2D6CYP2C19MEN1 | |
| SCHEMBL12744524 | 0.76 | PDE4D (0.40) | PDE4DMTNR1BMTNR1A | |
| SCHEMBL13064945 | 0.73 | LMNA (0.68) | PDE4DMTNR1BCYP3A4CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9181237-B2 | Substituted berbines and their synthesis | MALLINCKRODT LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150099772-A1 | SUBSTITUTED BERBINES AND THEIR SYNTHESIS | SUCAMPO PHARMA AMERICAS LLC | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099772-A1 | SUBSTITUTED BERBINES AND THEIR SYNTHESIS | TYMS, NME2, TYMP | PDE4D 3713/4885MTNR1B 3582/4885CYP3A4 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.